These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12668576)

  • 1. Rhabdomyolysis associated with pentamidine isethionate therapy for American cutaneous leishmaniasis.
    Delobel P; Pradinaud R
    J Antimicrob Chemother; 2003 May; 51(5):1319-20. PubMed ID: 12668576
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of American cutaneous leishmaniasis. Outcome apropos of 326 cases treated with high-dose pentamidine isethionate].
    Lightburn E; Morand JJ; Meynard JB; Kraemer P; Chaudier B; Pages F; Garnotel E; Patte JH; Banzet S; Dampierre H; Lepage J; Morillon M; Boutin JP; Hovette P; Chouc C
    Med Trop (Mars); 2003; 63(1):35-44. PubMed ID: 12891748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failure.
    Christen JR; Bourreau E; Demar M; Lightburn E; Couppié P; Ginouvès M; Prévot G; Gangneux JP; Savini H; de Laval F; Pommier de Santi V; Briolant S
    Travel Med Infect Dis; 2018; 24():31-36. PubMed ID: 29482012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of short-course intramuscular pentamidine isethionate treatment on Old World localized cutaneous leishmaniasis in 2 patients.
    Jauréguiberry S; Graby G; Caumes E
    Clin Infect Dis; 2006 Jun; 42(12):1812-3. PubMed ID: 16705598
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
    Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
    Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rhabdomyolysis induced by pentamidine (Pentacarinat) during treatment of cutaneous leishmaniasis: 2 cases].
    Lieber-Mbomeyo A; Lipsker D; Miléa M; Heid E
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):50-2. PubMed ID: 11937930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana.
    Roussel M; Nacher M; Frémont G; Rotureau B; Clyti E; Sainte-Marie D; Carme B; Pradinaud R; Couppié P
    Ann Trop Med Parasitol; 2006 Jun; 100(4):307-14. PubMed ID: 16762111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam.
    Lai A Fat EJ; Vrede MA; Soetosenojo RM; Lai A Fat RF
    Int J Dermatol; 2002 Nov; 41(11):796-800. PubMed ID: 12453009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Old World cutaneous leishmaniasis by pentamidine isethionate. An open study of 11 patients.
    Hellier I; Dereure O; Tournillac I; Pratlong F; Guillot B; Dedet JP; Guilhou JJ
    Dermatology; 2000; 200(2):120-3. PubMed ID: 10773699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of american cutaneous leishmaniasis, with lesions in the mucosa, using pentamidine isethionate].
    Amato VS; de Paula JG; Imamura R; Amato Neto V; Duarte MI; Boulos MI; Boulos M; Nicodemo AC; de Mendonca JS
    Rev Soc Bras Med Trop; 1996; 29(5):477-81. PubMed ID: 8966312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open label randomized clinical trial comparing the safety and effectiveness of one, two or three weekly pentamidine isethionate doses (seven milligrams per kilogram) in the treatment of cutaneous leishmaniasis in the Amazon Region.
    Gadelha EPN; Ramasawmy R; da Costa Oliveira B; Morais Rocha N; de Oliveira Guerra JA; Allan Villa Rouco da Silva G; Gabrielle Ramos de Mesquita T; Chrusciak Talhari Cortez C; Chrusciak Talhari A
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006850. PubMed ID: 30379814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana.
    Nacher M; Carme B; Sainte Marie D; Couppié P; Clyti E; Guibert P; Pradinaud R
    Ann Trop Med Parasitol; 2001 Jun; 95(4):331-6. PubMed ID: 11454242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentamidine isethionate as treatment and secondary prophylaxis for disseminated cutaneous leishmaniasis during HIV infection: case report.
    Calza L; Marinacci G; Manfredi R; Colangeli V; Fortunato L; Chiodo F
    J Chemother; 2001 Dec; 13(6):653-7. PubMed ID: 11806628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [26-year-old patient with cutaneous leishmaniasis and an initial diabetes mellitus manifestation].
    Herrmann BL; Saller B; Sauer J; Brockmeyer N; Mann K
    Internist (Berl); 1999 May; 40(5):561-4. PubMed ID: 10407766
    [No Abstract]   [Full Text] [Related]  

  • 15. Miltefosine Combined with Intralesional Pentamidine for
    Soto J; Soto P; Ajata A; Rivero D; Luque C; Tintaya C; Berman J
    Am J Trop Med Hyg; 2018 Nov; 99(5):1153-1155. PubMed ID: 30255833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment for cutaneous leishmaniasis: a review.
    Palumbo E
    Am J Ther; 2009; 16(2):178-82. PubMed ID: 19300044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis.
    Costa JM; Moraes MS; Saldanha AC; Barral A; Burattini MN
    Rev Soc Bras Med Trop; 1995; 28(4):405-7. PubMed ID: 8668842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20mgSbV/day for 20 days to treat cutaneous leishmaniasis].
    de Paula CD; Sampaio JH; Cardoso DR; Sampaio RN
    Rev Soc Bras Med Trop; 2003; 36(3):365-71. PubMed ID: 12908038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment.
    Bourreau E; Prévot G; Gardon J; Pradinaud R; Launois P
    J Infect Dis; 2001 Dec; 184(12):1628-30. PubMed ID: 11740743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns.
    Dorlo TP; Kager PA
    Trans R Soc Trop Med Hyg; 2010 Jan; 104(1):84-5; author reply 85. PubMed ID: 19836815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.